Hindustan Unilever Ltd
Hindustan Unilever is in the FMCG business comprising primarily of Home Care, Beauty & Personal Care and Foods & Refreshment segments. The Company has manufacturing facilities across the country and sells primarily in India.[1]
- Market Cap ₹ 5,48,371 Cr.
- Current Price ₹ 2,334
- High / Low ₹ 3,035 / 2,170
- Stock P/E 54.0
- Book Value ₹ 215
- Dividend Yield 1.80 %
- ROCE 27.2 %
- ROE 20.1 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 93.4%
Cons
- Stock is trading at 10.9 times its book value
- The company has delivered a poor sales growth of 9.61% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Multinational
Part of BSE Sensex Nifty 50 BSE 500 BSE Fast Moving Consumer Goods BSE 100
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
25,810 | 28,019 | 30,806 | 31,061 | 31,890 | 34,525 | 38,224 | 38,785 | 45,996 | 51,193 | 59,144 | 60,469 | 60,892 | |
21,796 | 23,532 | 25,600 | 25,312 | 25,843 | 27,249 | 29,587 | 29,185 | 34,672 | 38,690 | 45,512 | 46,279 | 46,664 | |
Operating Profit | 4,015 | 4,488 | 5,205 | 5,749 | 6,047 | 7,276 | 8,637 | 9,600 | 11,324 | 12,503 | 13,632 | 14,190 | 14,228 |
OPM % | 16% | 16% | 17% | 19% | 19% | 21% | 23% | 25% | 25% | 24% | 23% | 23% | 23% |
1,204 | 837 | 1,285 | 533 | 767 | 507 | 437 | 536 | 286 | 359 | 578 | 884 | 960 | |
Interest | 25 | 36 | 17 | 15 | 22 | 20 | 28 | 106 | 108 | 98 | 101 | 302 | 367 |
Depreciation | 236 | 261 | 287 | 321 | 396 | 478 | 524 | 938 | 1,012 | 1,025 | 1,030 | 1,097 | 1,174 |
Profit before tax | 4,958 | 5,028 | 6,187 | 5,946 | 6,396 | 7,285 | 8,522 | 9,092 | 10,490 | 11,739 | 13,079 | 13,675 | 13,647 |
Tax % | 23% | 23% | 30% | 30% | 30% | 28% | 29% | 26% | 24% | 25% | 24% | 26% | |
3,797 | 3,867 | 4,315 | 4,137 | 4,490 | 5,237 | 6,036 | 6,738 | 7,954 | 8,818 | 9,962 | 10,114 | 10,075 | |
EPS in Rs | 17.56 | 17.88 | 19.95 | 19.12 | 20.75 | 24.19 | 27.88 | 31.12 | 33.85 | 37.53 | 42.40 | 43.05 | 42.88 |
Dividend Payout % | 105% | 73% | 75% | 84% | 82% | 82% | 79% | 80% | 120% | 91% | 92% | 98% |
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 10% |
3 Years: | 10% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 10% |
3 Years: | 8% |
TTM: | -1% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 4% |
3 Years: | 0% |
1 Year: | -9% |
Return on Equity | |
---|---|
10 Years: | 32% |
5 Years: | 24% |
3 Years: | 20% |
Last Year: | 20% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 216 | 216 | 216 | 216 | 216 | 216 | 216 | 216 | 235 | 235 | 235 | 235 | 235 |
Reserves | 2,458 | 3,061 | 3,508 | 6,063 | 6,274 | 6,859 | 7,443 | 7,815 | 47,199 | 48,525 | 49,986 | 50,738 | 50,244 |
-0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 943 | 971 | 1,039 | 1,374 | 1,532 | |
8,838 | 9,721 | 9,909 | 7,641 | 8,261 | 10,074 | 10,206 | 11,571 | 19,739 | 20,006 | 20,565 | 24,729 | 27,277 | |
Total Liabilities | 11,512 | 12,998 | 13,634 | 13,920 | 14,751 | 17,149 | 17,865 | 19,602 | 68,116 | 69,737 | 71,825 | 77,076 | 79,288 |
2,293 | 2,422 | 2,458 | 2,914 | 4,024 | 4,142 | 4,343 | 5,056 | 51,027 | 51,034 | 51,405 | 52,379 | 52,610 | |
CWIP | 216 | 320 | 479 | 386 | 203 | 430 | 373 | 513 | 623 | 901 | 1,020 | 915 | 966 |
Investments | 2,331 | 3,094 | 3,278 | 2,780 | 3,779 | 3,111 | 2,949 | 1,500 | 2,995 | 4,122 | 3,794 | 5,493 | 5,140 |
6,673 | 7,162 | 7,420 | 7,840 | 6,745 | 9,466 | 10,200 | 12,533 | 13,471 | 13,680 | 15,606 | 18,289 | 20,572 | |
Total Assets | 11,512 | 12,998 | 13,634 | 13,920 | 14,751 | 17,149 | 17,865 | 19,602 | 68,116 | 69,737 | 71,825 | 77,076 | 79,288 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3,530 | 3,724 | 3,272 | 3,974 | 4,953 | 5,913 | 5,728 | 7,305 | 8,957 | 8,964 | 9,626 | 14,884 | |
34 | -513 | 280 | -51 | -752 | -1,261 | -264 | 1,926 | -1,067 | -1,732 | -1,062 | -4,971 | |
-4,160 | -2,917 | -3,450 | -4,008 | -4,264 | -4,651 | -5,462 | -6,676 | -9,280 | -7,984 | -8,966 | -9,890 | |
Net Cash Flow | -597 | 294 | 101 | -85 | -63 | 1 | 2 | 2,555 | -1,390 | -752 | -402 | 23 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 12 | 11 | 9 | 12 | 11 | 12 | 16 | 10 | 13 | 14 | 17 | 16 |
Inventory Days | 80 | 83 | 72 | 71 | 65 | 62 | 57 | 63 | 64 | 63 | 53 | 52 |
Days Payable | 164 | 170 | 146 | 155 | 165 | 186 | 167 | 177 | 162 | 145 | 122 | 139 |
Cash Conversion Cycle | -72 | -76 | -65 | -71 | -89 | -111 | -94 | -104 | -86 | -67 | -53 | -71 |
Working Capital Days | -51 | -57 | -55 | -27 | -35 | -39 | -32 | -33 | -31 | -22 | -16 | -21 |
ROCE % | 135% | 154% | 150% | 120% | 97% | 109% | 119% | 120% | 38% | 24% | 26% | 27% |
Documents
Announcements
-
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
2d - Disclosure of penalty order under CGST Act.
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
13 Dec - Intimation of loss of share certificates and issuance of duplicates.
-
Closure of Trading Window
13 Dec - Closure of trading window from 16th December 2024.
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
12 Dec - Intimation of loss of share certificates and issuance of duplicates.
-
Announcement under Regulation 30 (LODR)-Change in Management
11 Dec - Appointment of Dr. Vivek Mittal as Executive Director.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024TranscriptNotesPPT
-
Oct 2024Transcript PPT
-
Jul 2024Transcript PPT
-
Apr 2024TranscriptPPT
-
Apr 2024Transcript PPT REC
-
Apr 2024TranscriptNotesPPT
-
Mar 2024TranscriptNotesPPT
-
Jan 2024Transcript PPT
-
Oct 2023Transcript PPT
-
Jul 2023Transcript PPT
-
May 2023Transcript PPT REC
-
Jan 2023TranscriptNotesPPT
-
Dec 2022TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Oct 2022TranscriptNotesPPT
-
Jul 2022TranscriptNotesPPT
-
Apr 2022Transcript PPT
-
Apr 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Dec 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Oct 2021TranscriptNotesPPT
-
Sep 2021TranscriptNotesPPT
-
Sep 2021TranscriptNotesPPT
-
Jul 2021TranscriptNotesPPT
-
Jun 2021Transcript PPT
-
Apr 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Jan 2021TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
-
Oct 2020TranscriptNotesPPT
-
Sep 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Apr 2020TranscriptNotesPPT
-
Apr 2020TranscriptNotesPPT
-
Jan 2020TranscriptNotesPPT
-
Dec 2019TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Oct 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Jul 2019TranscriptNotesPPT
-
Jun 2019TranscriptNotesPPT
-
Jun 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
Jan 2019TranscriptNotesPPT
-
Dec 2018TranscriptNotesPPT
-
Dec 2018TranscriptNotesPPT
-
Dec 2018TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Oct 2018TranscriptNotesPPT
-
Sep 2018TranscriptNotesPPT
-
Sep 2018TranscriptNotesPPT
-
Jun 2018TranscriptNotesPPT
-
May 2018Transcript PPT
-
May 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Jan 2018TranscriptNotesPPT
-
Oct 2017TranscriptNotesPPT
-
Sep 2017TranscriptNotesPPT
-
Sep 2017TranscriptNotesPPT
-
Sep 2017TranscriptNotesPPT
-
Jun 2017TranscriptNotesPPT
-
Jun 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Nov 2016TranscriptNotesPPT
-
Oct 2016TranscriptNotesPPT
-
Jul 2016Transcript PPT
-
Jan 2016TranscriptNotesPPT
Business Segments & Brand Portfolio
The company has a portfolio of over 50 brands, spanning 16 FMCG categories, including 19 brands with a turnover of more than Rs. 1,000 Cr PA. [1] The products are split into the following segments: